FLOWer
Embolic protection during Transcatheter Aortic Valve Implantation (TAVI)
Pre-clinicalActive
Key Facts
Indication
Embolic protection during Transcatheter Aortic Valve Implantation (TAVI)
Phase
Pre-clinical
Status
Active
Company
About AorticLab
AorticLab is a private, pre-revenue medical device innovator developing the FLOWer, a novel embolic protection device for TAVI procedures. The company aims to reduce stroke and other embolic risks by capturing debris with a 60 µm mesh deployed in the aortic arch, offering full-body protection. With a leadership team combining clinical, regulatory, and engineering expertise, and established distributor partnerships in Europe, AorticLab is positioned to address a significant unmet need in the growing structural heart market, though it faces competition and the inherent challenges of regulatory approval and market adoption.
View full company profile